TiGenix reconfirms its strategic focus on its allogeneic stem cell platforms – Yahoo Finance
|
TiGenix reconfirms its strategic focus on its allogeneic stem cell platforms
Yahoo Finance "TiGenix continues to be committed to bring novel therapeutics based on our proprietary allogeneic stem cell platforms to patients with high unmet medical need, as was evidenced by the recently announced licensing agreement with Takeda Pharmaceutical … |
